BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Solizmestrocel readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Solizmestrocel\, from ClinicalTrials.gov 
 estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06491043-1552@assetmemo.bio
DTSTAMP:20261121T004539Z
DTSTART;VALUE=DATE:20261230
DTEND;VALUE=DATE:20261231
SUMMARY:Solizmestrocel: Phase 2 readout est. (NCT06491043)
DESCRIPTION:Solizmestrocel\, phase 2\, Chronic Obstructive Pulmonary Diseas
 e.\nStudy: Treatment of Chronic Obstructive Pulmonary Disease by Infusion 
 of Allogenic Mesenchymal Stem Cells\nEstimated primary completion: 30 Dece
 mber 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/solizmestr
 ocel#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NC
 T06491043
URL:https://assetmemo.bio/drug/solizmestrocel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
